Tazarotene 0.1% cream versus tretinoin 0.05% emollient cream in the treatment of photodamaged, facial skin: A multicenter, doubleblind, randomized, parallel-group study

被引：0

作者：

Lowe, N

Kang, S

Tanghetti, E

Poulin, Y

机构：

[1] Univ Calif Los Angeles, Sch Med, Santa Monica, CA USA

[2] Univ Michigan, Med Ctr, Ann Arbor, MI USA

[3] Univ Calif Davis, Sacramento, CA 95817 USA

[4] Ctr Hosp Univ Quebec, Quebec City, PQ, Canada

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2004年 / 50卷 / 03期

关键词：

D O I：

10.1016/j.jaad.2003.10.116

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

P11

引用

页码：P28 / P28

页数：1

共 50 条

[1] Tazarotene cream for the treatment of facial photodamage - A multicenter, investigator-masked, randomized, vehicle-controlled, parallel comparison of 0.01%, 0.025%, 0.05%, and 0.1% tazarotene creams with 0.05% tretinoin emollient cream applied once daily for 24 weeks
Kang, SW
Leyden, JJ
Lowe, NJ
Ortonne, JP
Phillips, TJ
Weinstein, GD
Bhawan, J
Lew-Kaya, DA
Matsumoto, RM
Sefton, J
Walker, PS
Gibson, JR
ARCHIVES OF DERMATOLOGY, 2001, 137 (12) : 1597 - 1604
[2] Novel approach to the treatment of hyperpigmented photodamaged skin: 4% hydroquinone/0.3% retinol versus tretinoin 0.05% emollient cream
Draelos, ZD
DERMATOLOGIC SURGERY, 2005, 31 (07) : 799 - 804
[3] Long-term safety and histopathologic changes following treatment of photodamaged facial skin with tretinoin emollient cream 0.05% in darkly pigmented subjects
Grossman, Rachel
Nighland, Margaret
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 56 (02) : AB27 - AB27
[4] Long-term efficacy and safety of tretinoin emollient cream 0.05% in the treatment of photodamaged facial skin - A two-year, randomized, placebo-controlled trial
Kang, SW
Bergfeld, W
Gottlieb, AB
Hickman, J
Humeniuk, J
Kempers, S
Lebwohl, M
Lowe, N
McMichael, A
Milbauer, J
Phillips, T
Powers, J
Rodriguez, D
Savin, R
Shavin, J
Sherer, D
Silvis, N
Weinstein, R
Weiss, J
Hammerberg, C
Fisher, GJ
Nighland, M
Grossman, R
Nyirady, J
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2005, 6 (04) : 245 - 253
[5] Tazarotene versus tazarotene plus hydroquinone in the treatment of photodamaged facial skin: A multicenter, double-blind, randomized study
Lowe, N
Horwitz, S
Tanghetti, E
Draelos, Z
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (03) : P32 - P32
[6] Cost-effectiveness of tazarotene 0.1% cream versus adapalene 0.1% cream for the treatment of facial acne vulgaris
Lee, JT
Kowalski, J
Ravelo, A
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 50 (03) : P23 - P23
[7] Tretinoin emollient cream for photodamaged skin: Results of 48-week, multicenter, double-blind studies
Olsen, EA
Katz, HI
Levine, N
Nigra, TP
Pochi, PE
Savin, RC
Shupack, J
Weinstein, GD
Lufrano, L
Perry, BH
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1997, 37 (02) : 217 - 226
[8] Long-Term Efficacy and Safety of Tretinoin Emollient Cream 0.05% in the Treatment of Photodamaged Facial SkinA Two-Year, Randomized, Placebo-Controlled Trial
Sewon Kang
Wilma Bergfeld
Alice B. Gottlieb
Janet Hickman
John Humeniuk
Steven Kempers
Mark Lebwohl
Nicholas Lowe
Amy McMichael
James Milbauer
Tania Phillips
Jerold Powers
David Rodriguez
Ronald Savin
Joel Shavin
Daniel Sherer
Nancy Silvis
Richard Weinstein
Jonathan Weiss
Craig Hammerberg
Gary J Fisher
Marge Nighland
Rachel Grossman
Judit Nyirady
American Journal of Clinical Dermatology, 2005, 6 : 245 - 253
[9] Effects of tazarotene 0.1% cream in the treatment of facial acne vulgaris: Pooled results from two multicenter, double-blind, randomized, vehicle-controlled, parallel-group trials
Shalita, AR
Berson, DS
Thiboutot, DM
Leyden, JJ
Parizadeh, D
Sefton, J
Walker, PS
Gibson, JR
CLINICAL THERAPEUTICS, 2004, 26 (11) : 1865 - 1873
[10] Tretinoin Microsphere Gel Pump 0.04% Versus Tazarotene Cream 0.05% in the Treatment of Mild-to-Moderate Facial Acne Vulgaris
Kircik, Leon H.
JOURNAL OF DRUGS IN DERMATOLOGY, 2009, 8 (07) : 650 - 654

← 1 2 3 4 5 →